The placement is a bright spot in an otherwise quiet period for psychedelics industry financing, as investors grow selective.

Amid improving sector sentiment, Actinogen says its Alzheimer’s trial is off to a flier Telix shares start trading on the ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics is undergoing a strategic board reshuffle as Non-Executive ...

Rockville, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- According to a new industry report by Fact.MR, the global tryptamine API market is projected to be worth US$ 757.2 million in 2024 and thereafter ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics, a biotech company listed on ASX, announced the results of its 2024 Annual General Meeting, where all resolutions ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics Limited (ASX: TYP) has requested a trading ...

Followed categories will be added to My News. In this episode, host Fraser Palamara dissects the $6 million raising completed ...

Tryptamine receives firm commitments to raise $6m in placement strongly supported by new and existing stakeholders Placement cornerstoned by Merchant Biotech Fund and biotech investor Dr Daniel ...

Enveric Biosciences expands its patent portfolio with five new U.S. patents, supporting treatments for depression, anxiety ...

Tryptamine Therapeutics Limited annonce la démission de Peter Molloy en tant qu'administrateur non exécutif du Conseil d'administration, à compter du 8 novembre 2024 05/11 CI Tryptamine Therapeutics ...

Followed categories will be added to My News. Tryptamine receives firm commitments to raise $6m in placement strongly supported by new and existing stakeholders Placement cornerstoned by Merchant ...